1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Periodic Paralysis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Beta-Blockers 1.2.3 Carbonic Anhydrase Inhibitor 1.2.4 Others 1.3 Market by Application 1.3.1 Global Periodic Paralysis Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hypokalemic Periodic Paralysis 1.3.3 Hyperkalemic Periodic Paralysis 1.3.4 Thyrotoxic Periodic Paralysis 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Periodic Paralysis Treatment Market Perspective (2016-2027) 2.2 Periodic Paralysis Treatment Growth Trends by Regions 2.2.1 Periodic Paralysis Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Periodic Paralysis Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Periodic Paralysis Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Periodic Paralysis Treatment Industry Dynamic 2.3.1 Periodic Paralysis Treatment Market Trends 2.3.2 Periodic Paralysis Treatment Market Drivers 2.3.3 Periodic Paralysis Treatment Market Challenges 2.3.4 Periodic Paralysis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Periodic Paralysis Treatment Players by Revenue 3.1.1 Global Top Periodic Paralysis Treatment Players by Revenue (2016-2021) 3.1.2 Global Periodic Paralysis Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Periodic Paralysis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Periodic Paralysis Treatment Revenue 3.4 Global Periodic Paralysis Treatment Market Concentration Ratio 3.4.1 Global Periodic Paralysis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Periodic Paralysis Treatment Revenue in 2020 3.5 Periodic Paralysis Treatment Key Players Head office and Area Served 3.6 Key Players Periodic Paralysis Treatment Product Solution and Service 3.7 Date of Enter into Periodic Paralysis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Periodic Paralysis Treatment Breakdown Data by Type 4.1 Global Periodic Paralysis Treatment Historic Market Size by Type (2016-2021) 4.2 Global Periodic Paralysis Treatment Forecasted Market Size by Type (2022-2027) 5 Periodic Paralysis Treatment Breakdown Data by Application 5.1 Global Periodic Paralysis Treatment Historic Market Size by Application (2016-2021) 5.2 Global Periodic Paralysis Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Periodic Paralysis Treatment Market Size (2016-2027) 6.2 North America Periodic Paralysis Treatment Market Size by Type 6.2.1 North America Periodic Paralysis Treatment Market Size by Type (2016-2021) 6.2.2 North America Periodic Paralysis Treatment Market Size by Type (2022-2027) 6.2.3 North America Periodic Paralysis Treatment Market Size by Type (2016-2027) 6.3 North America Periodic Paralysis Treatment Market Size by Application 6.3.1 North America Periodic Paralysis Treatment Market Size by Application (2016-2021) 6.3.2 North America Periodic Paralysis Treatment Market Size by Application (2022-2027) 6.3.3 North America Periodic Paralysis Treatment Market Size by Application (2016-2027) 6.4 North America Periodic Paralysis Treatment Market Size by Country 6.4.1 North America Periodic Paralysis Treatment Market Size by Country (2016-2021) 6.4.2 North America Periodic Paralysis Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Periodic Paralysis Treatment Market Size (2016-2027) 7.2 Europe Periodic Paralysis Treatment Market Size by Type 7.2.1 Europe Periodic Paralysis Treatment Market Size by Type (2016-2021) 7.2.2 Europe Periodic Paralysis Treatment Market Size by Type (2022-2027) 7.2.3 Europe Periodic Paralysis Treatment Market Size by Type (2016-2027) 7.3 Europe Periodic Paralysis Treatment Market Size by Application 7.3.1 Europe Periodic Paralysis Treatment Market Size by Application (2016-2021) 7.3.2 Europe Periodic Paralysis Treatment Market Size by Application (2022-2027) 7.3.3 Europe Periodic Paralysis Treatment Market Size by Application (2016-2027) 7.4 Europe Periodic Paralysis Treatment Market Size by Country 7.4.1 Europe Periodic Paralysis Treatment Market Size by Country (2016-2021) 7.4.2 Europe Periodic Paralysis Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Periodic Paralysis Treatment Market Size (2016-2027) 8.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Type 8.2.1 Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Periodic Paralysis Treatment Market Size by Application 8.3.1 Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Periodic Paralysis Treatment Market Size by Region 8.4.1 Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Periodic Paralysis Treatment Market Size (2016-2027) 9.2 Latin America Periodic Paralysis Treatment Market Size by Type 9.2.1 Latin America Periodic Paralysis Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Periodic Paralysis Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Periodic Paralysis Treatment Market Size by Type (2016-2027) 9.3 Latin America Periodic Paralysis Treatment Market Size by Application 9.3.1 Latin America Periodic Paralysis Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Periodic Paralysis Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Periodic Paralysis Treatment Market Size by Application (2016-2027) 9.4 Latin America Periodic Paralysis Treatment Market Size by Country 9.4.1 Latin America Periodic Paralysis Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Periodic Paralysis Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Periodic Paralysis Treatment Market Size (2016-2027) 10.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Type 10.2.1 Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Periodic Paralysis Treatment Market Size by Application 10.3.1 Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Periodic Paralysis Treatment Market Size by Country 10.4.1 Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Strongbridge Biopharma 11.1.1 Strongbridge Biopharma Company Details 11.1.2 Strongbridge Biopharma Business Overview 11.1.3 Strongbridge Biopharma Periodic Paralysis Treatment Introduction 11.1.4 Strongbridge Biopharma Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.1.5 Strongbridge Biopharma Recent Development 11.2 Sun Pharmaceutical Industries Ltd 11.2.1 Sun Pharmaceutical Industries Ltd Company Details 11.2.2 Sun Pharmaceutical Industries Ltd Business Overview 11.2.3 Sun Pharmaceutical Industries Ltd Periodic Paralysis Treatment Introduction 11.2.4 Sun Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.2.5 Sun Pharmaceutical Industries Ltd Recent Development 11.3 Mylan N.V. 11.3.1 Mylan N.V. Company Details 11.3.2 Mylan N.V. Business Overview 11.3.3 Mylan N.V. Periodic Paralysis Treatment Introduction 11.3.4 Mylan N.V. Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.3.5 Mylan N.V. Recent Development 11.4 Cadila Healthcare 11.4.1 Cadila Healthcare Company Details 11.4.2 Cadila Healthcare Business Overview 11.4.3 Cadila Healthcare Periodic Paralysis Treatment Introduction 11.4.4 Cadila Healthcare Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.4.5 Cadila Healthcare Recent Development 11.5 Alembic Pharmaceuticals 11.5.1 Alembic Pharmaceuticals Company Details 11.5.2 Alembic Pharmaceuticals Business Overview 11.5.3 Alembic Pharmaceuticals Periodic Paralysis Treatment Introduction 11.5.4 Alembic Pharmaceuticals Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.5.5 Alembic Pharmaceuticals Recent Development 11.6 Teva Pharmaceutical Industries Ltd 11.6.1 Teva Pharmaceutical Industries Ltd Company Details 11.6.2 Teva Pharmaceutical Industries Ltd Business Overview 11.6.3 Teva Pharmaceutical Industries Ltd Periodic Paralysis Treatment Introduction 11.6.4 Teva Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.6.5 Teva Pharmaceutical Industries Ltd Recent Development 11.7 X-GEN Pharmaceuticals, Inc 11.7.1 X-GEN Pharmaceuticals, Inc Company Details 11.7.2 X-GEN Pharmaceuticals, Inc Business Overview 11.7.3 X-GEN Pharmaceuticals, Inc Periodic Paralysis Treatment Introduction 11.7.4 X-GEN Pharmaceuticals, Inc Revenue in Periodic Paralysis Treatment Business (2016-2021) 11.7.5 X-GEN Pharmaceuticals, Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Periodic Paralysis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Beta-Blockers Table 3. Key Players of Carbonic Anhydrase Inhibitor Table 4. Key Players of Others Table 5. Global Periodic Paralysis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Periodic Paralysis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Periodic Paralysis Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Periodic Paralysis Treatment Market Share by Regions (2016-2021) Table 9. Global Periodic Paralysis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Periodic Paralysis Treatment Market Share by Regions (2022-2027) Table 11. Periodic Paralysis Treatment Market Trends Table 12. Periodic Paralysis Treatment Market Drivers Table 13. Periodic Paralysis Treatment Market Challenges Table 14. Periodic Paralysis Treatment Market Restraints Table 15. Global Periodic Paralysis Treatment Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Periodic Paralysis Treatment Market Share by Players (2016-2021) Table 17. Global Top Periodic Paralysis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Periodic Paralysis Treatment as of 2020) Table 18. Ranking of Global Top Periodic Paralysis Treatment Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Periodic Paralysis Treatment Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Periodic Paralysis Treatment Product Solution and Service Table 22. Date of Enter into Periodic Paralysis Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million) Table 25. Global Periodic Paralysis Treatment Revenue Market Share by Type (2016-2021) Table 26. Global Periodic Paralysis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Periodic Paralysis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Periodic Paralysis Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Periodic Paralysis Treatment Revenue Market Share by Application (2016-2021) Table 30. Global Periodic Paralysis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Periodic Paralysis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million) Table 33. North America Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million) Table 35. North America Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 62. Strongbridge Biopharma Company Details Table 63. Strongbridge Biopharma Business Overview Table 64. Strongbridge Biopharma Periodic Paralysis Treatment Product Table 65. Strongbridge Biopharma Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 66. Strongbridge Biopharma Recent Development Table 67. Sun Pharmaceutical Industries Ltd Company Details Table 68. Sun Pharmaceutical Industries Ltd Business Overview Table 69. Sun Pharmaceutical Industries Ltd Periodic Paralysis Treatment Product Table 70. Sun Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 71. Sun Pharmaceutical Industries Ltd Recent Development Table 72. Mylan N.V. Company Details Table 73. Mylan N.V. Business Overview Table 74. Mylan N.V. Periodic Paralysis Treatment Product Table 75. Mylan N.V. Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 76. Mylan N.V. Recent Development Table 77. Cadila Healthcare Company Details Table 78. Cadila Healthcare Business Overview Table 79. Cadila Healthcare Periodic Paralysis Treatment Product Table 80. Cadila Healthcare Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 81. Cadila Healthcare Recent Development Table 82. Alembic Pharmaceuticals Company Details Table 83. Alembic Pharmaceuticals Business Overview Table 84. Alembic Pharmaceuticals Periodic Paralysis Treatment Product Table 85. Alembic Pharmaceuticals Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 86. Alembic Pharmaceuticals Recent Development Table 87. Teva Pharmaceutical Industries Ltd Company Details Table 88. Teva Pharmaceutical Industries Ltd Business Overview Table 89. Teva Pharmaceutical Industries Ltd Periodic Paralysis Treatment Product Table 90. Teva Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 91. Teva Pharmaceutical Industries Ltd Recent Development Table 92. X-GEN Pharmaceuticals, Inc Company Details Table 93. X-GEN Pharmaceuticals, Inc Business Overview Table 94. X-GEN Pharmaceuticals, Inc Periodic Paralysis Treatment Product Table 95. X-GEN Pharmaceuticals, Inc Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million) Table 96. X-GEN Pharmaceuticals, Inc Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Periodic Paralysis Treatment Market Share by Type: 2020 VS 2027 Figure 2. Beta-Blockers Features Figure 3. Carbonic Anhydrase Inhibitor Features Figure 4. Others Features Figure 5. Global Periodic Paralysis Treatment Market Share by Application: 2020 VS 2027 Figure 6. Hypokalemic Periodic Paralysis Case Studies Figure 7. Hyperkalemic Periodic Paralysis Case Studies Figure 8. Thyrotoxic Periodic Paralysis Case Studies Figure 9. Others Case Studies Figure 10. Periodic Paralysis Treatment Report Years Considered Figure 11. Global Periodic Paralysis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Periodic Paralysis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Periodic Paralysis Treatment Market Share by Regions: 2020 VS 2027 Figure 14. Global Periodic Paralysis Treatment Market Share by Regions (2022-2027) Figure 15. Global Periodic Paralysis Treatment Market Share by Players in 2020 Figure 16. Global Top Periodic Paralysis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Periodic Paralysis Treatment as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Periodic Paralysis Treatment Revenue in 2020 Figure 18. Global Periodic Paralysis Treatment Revenue Market Share by Type (2016-2021) Figure 19. Global Periodic Paralysis Treatment Revenue Market Share by Type (2022-2027) Figure 20. North America Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Periodic Paralysis Treatment Market Share by Type (2016-2027) Figure 22. North America Periodic Paralysis Treatment Market Share by Application (2016-2027) Figure 23. North America Periodic Paralysis Treatment Market Share by Country (2016-2027) Figure 24. United States Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Periodic Paralysis Treatment Market Share by Type (2016-2027) Figure 28. Europe Periodic Paralysis Treatment Market Share by Application (2016-2027) Figure 29. Europe Periodic Paralysis Treatment Market Share by Country (2016-2027) Figure 30. Germany Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Periodic Paralysis Treatment Market Share by Type (2016-2027) Figure 38. Asia-Pacific Periodic Paralysis Treatment Market Share by Application (2016-2027) Figure 39. Asia-Pacific Periodic Paralysis Treatment Market Share by Region (2016-2027) Figure 40. China Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Periodic Paralysis Treatment Market Share by Type (2016-2027) Figure 48. Latin America Periodic Paralysis Treatment Market Share by Application (2016-2027) Figure 49. Latin America Periodic Paralysis Treatment Market Share by Country (2016-2027) Figure 50. Mexico Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Periodic Paralysis Treatment Market Share by Type (2016-2027) Figure 54. Middle East & Africa Periodic Paralysis Treatment Market Share by Application (2016-2027) Figure 55. Middle East & Africa Periodic Paralysis Treatment Market Share by Country (2016-2027) Figure 56. Turkey Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Strongbridge Biopharma Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 60. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 61. Mylan N.V. Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 62. Cadila Healthcare Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 63. Alembic Pharmaceuticals Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 64. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 65. X-GEN Pharmaceuticals, Inc Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Strongbridge Biopharma Sun Pharmaceutical Industries Ltd Mylan N.V. Cadila Healthcare Alembic Pharmaceuticals Teva Pharmaceutical Industries Ltd X-GEN Pharmaceuticals, Inc